HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angelo Ravelli Selected Research

Juvenile Arthritis (Juvenile Idiopathic Arthritis)

11/2022Canakinumab in systemic juvenile idiopathic arthritis: real-world data from a retrospective Italian cohort.
1/2022Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis.
11/2021Underlying CTLA4 Deficiency in a Patient With Juvenile Idiopathic Arthritis and Autoimmune Lymphoproliferative Syndrome Features Successfully Treated With Abatacept-A Case Report.
3/2021Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis.
1/2021Novel biomarkers for prediction of outcome and therapeutic response in juvenile idiopathic arthritis.
10/2020Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials.
12/2019Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.
11/2019Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus survey.
8/2019Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis.
7/2019A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Angelo Ravelli Research Topics

Disease

46Juvenile Arthritis (Juvenile Idiopathic Arthritis)
11/2022 - 01/2002
22Arthritis (Polyarthritis)
01/2022 - 05/2003
14Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2021 - 09/2005
13Dermatomyositis (Dermatopolymyositis)
01/2021 - 11/2002
11Macrophage Activation Syndrome
10/2022 - 03/2010
9Pain (Aches)
01/2022 - 12/2006
8Fever (Fevers)
10/2022 - 04/2011
7Myositis (Idiopathic Inflammatory Myopathies)
01/2021 - 11/2002
6Uveitis
01/2022 - 08/2003
6Lupus Nephritis
10/2021 - 05/2015
5Rheumatic Diseases (Rheumatism)
06/2022 - 01/2008
4Arthralgia (Joint Pain)
10/2022 - 12/2006
4Iridocyclitis
07/2021 - 03/2005
4Infections
08/2019 - 12/2012
4Joint Diseases (Joint Disease)
02/2014 - 03/2005
3Inflammation (Inflammations)
10/2022 - 12/2007
3Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2021 - 04/2005
3Proteinuria
01/2021 - 05/2010
3Vasculitis (Vasculitides)
01/2021 - 01/2019
3Adult-Onset Still's Disease
11/2020 - 12/2019
3Rheumatoid Arthritis
07/2016 - 08/2015
3Synovitis
07/2013 - 01/2010
2Lung Diseases (Lung Disease)
10/2022 - 07/2020
2Splenomegaly
01/2022 - 10/2017
2Hemorrhage
08/2021 - 05/2005
2Takayasu Arteritis (Arteritis, Takayasu's)
03/2021 - 09/2008
2Cytokine Release Syndrome
01/2021 - 01/2020
2COVID-19
01/2021 - 07/2020
2Pericarditis
06/2020 - 02/2014
2Glomerulonephritis
01/2020 - 08/2015
2Necrosis
10/2017 - 07/2013
2Body Weight (Weight, Body)
12/2012 - 02/2012
2Hyperferritinemia
04/2011 - 11/2009
2Hypertriglyceridemia
04/2011 - 11/2009
1Abdominal Pain (Pain, Abdominal)
10/2022
1Exanthema (Rash)
10/2022
1Rubella (German Measles)
06/2022
1Mumps
06/2022
1Measles
06/2022
1Shock
01/2022
1Chickenpox
12/2021
1Autoimmune Lymphoproliferative Syndrome
11/2021
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
11/2021
1Cytopenia
11/2021
1Neonatal Systemic lupus erythematosus
11/2021
1Agammaglobulinemia (Hypogammaglobulinemia)
10/2021
1Lymphadenopathy
10/2021
1Reinfection
10/2021

Drug/Important Bio-Agent (IBA)

17Methotrexate (Mexate)FDA LinkGeneric
03/2021 - 09/2007
14Biological ProductsIBA
06/2022 - 07/2013
9Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 08/2003
8Antinuclear AntibodiesIBA
07/2021 - 08/2003
7AntibodiesIBA
11/2021 - 08/2015
6Antirheumatic Agents (DMARD)IBA
06/2022 - 01/2015
6Interleukin-1 (Interleukin 1)IBA
01/2021 - 05/2008
6Prednisone (Sone)FDA LinkGeneric
05/2019 - 01/2015
5Ferritins (Ferritin)IBA
10/2022 - 10/2014
5Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2021 - 01/2019
5GlucocorticoidsIBA
01/2021 - 05/2003
5AutoantibodiesIBA
01/2021 - 05/2015
5C-Reactive ProteinIBA
07/2019 - 12/2006
5Rheumatoid FactorIBA
01/2019 - 03/2005
4canakinumabFDA Link
11/2022 - 02/2012
4Acute-Phase Proteins (Acute-Phase Protein)IBA
10/2022 - 09/2011
4Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2014
4Antiphospholipid AntibodiesIBA
01/2021 - 04/2005
4Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2019 - 02/2016
4ametantrone (HAQ)IBA
01/2010 - 05/2003
3SteroidsIBA
11/2021 - 01/2020
3Deoxyribonucleases (DNase)FDA Link
10/2021 - 01/2020
3Intravenous Immunoglobulins (IVIG)FDA Link
10/2021 - 01/2021
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2021 - 11/2009
3Fibrinogen (Factor I)FDA Link
08/2021 - 10/2017
3MethylprednisoloneFDA LinkGeneric
01/2021 - 01/2015
3tocilizumab (atlizumab)FDA Link
10/2020 - 12/2012
3Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2002
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
11/2021 - 10/2021
2Immunoglobulin G (IgG)IBA
01/2021 - 01/2021
2ColchicineFDA LinkGeneric
01/2020 - 01/2020
2AntigensIBA
01/2020 - 08/2015
2InterferonsIBA
01/2019 - 01/2017
2CreatinineIBA
01/2019 - 11/2009
2Rituximab (Mabthera)FDA Link
05/2017 - 01/2017
2Etanercept (Enbrel)FDA Link
12/2016 - 02/2013
2Tumor Necrosis Factor InhibitorsIBA
07/2013 - 09/2008
2PerforinIBA
03/2010 - 09/2002
2Macrophage Migration-Inhibitory FactorsIBA
05/2003 - 01/2002
1VaccinesIBA
06/2022
1Attenuated VaccinesIBA
06/2022
12,6-dinitrotoluene (DNT)IBA
01/2022
1N-phthaloylglutamic acidIBA
01/2022
1Antiviral Agents (Antivirals)IBA
12/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2021
1Abatacept (Orencia)FDA Link
11/2021
1Sirolimus (Rapamycin)FDA Link
11/2021
1DNA (Deoxyribonucleic Acid)IBA
10/2021

Therapy/Procedure

37Therapeutics
01/2022 - 08/2003
5Injections
06/2020 - 08/2003
2Transitional Care
11/2019 - 11/2018
1Critical Care (Surgical Intensive Care)
01/2022